FREDERICK, Md., March 11, 2014 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices has appointed Dr. Deepak Kotak MA (Oxford), MBBS, FRCA, MRCP, LLDip, LLM as Executive Vice President.
"Dr. Kotak brings a wealth of knowledge and experience that will help lead BioElectronics to the next level of development," said Andrew J. Whelan, BioElectronics President. "Dr Kotak has a rare and valuable combination of credentials: medical, legal, pharmaceutical and entrepreneurial."
With the appointment of Dr. Kotak who lives in London, BioElectronics will have a greater presence in Europe to further promote the ActiPatch Therapy product line that is available OTC in Boots. Dr. Kotak will provide leadership and management for the RecoveryRx product line as well as undertaking medical affairs, clinical research and new product development activities. He joins BioElectronics at an exciting time as international sales begin to gain greater traction and after the very recent recommendation by the FDA to reclassify Shortwave Medical Devices to Class II.
Prior to his appointment, Dr. Kotak has been Chief Medical Officer of TraumaTec, a Houston medical device company as well as a consultant to the Boss Group and Blackstone Valley Group, two private equity firms.
Dr. Kotak brings a broad medical background and perspective having practiced as a specialist in intensive care medicine, anesthesia and trauma in a London teaching hospital. Dr. Kotak has also practiced for four years as a civil lawyer. Dr. Kotak graduated in medicine with degrees from Oxford University and the University of London.
About BioElectronics Corporation
BioElectronics Corporation is a leader in biophysics and the maker of an industry leading family of disposable, drug-free, pain therapy devices: ActiPatch® Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx® Devices for chronic and post-operative wound care; Allay® Menstrual Pain Therapy; and HealFast® Therapy for dogs, cats and horses. For more information, please visit www.bielcorp.com.
SOURCE BioElectronics Corporation